By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Mydriatics > Homatropaire > Homatropine Ophthalmic Dosage
Mydriatics
https://themeditary.com/dosage-information/homatropine-ophthalmic-dosage-9300.html

Homatropine Ophthalmic Dosage

Drug Detail:Homatropaire (Homatropine ophthalmic [ hoe-ma-troe-peen ])

Drug Class: Mydriatics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Refraction

Instill 1 to 2 drops into the eye(s) once; may repeat in 5 to 10 minutes if needed

Comments:

  • This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.

Usual Adult Dose for Uveitis

Instill 1 to 2 drops into the eye(s) up to every 3 to 4 hours

Comments:

  • This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.

Usual Pediatric Dose for Refraction

Greater than 3 months: Instill 1 to 2 drops into the eye(s) once; may repeat in 5 to 10 minutes if needed

Comments:

  • This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.

Usual Pediatric Dose for Uveitis

Greater than 3 months: Instill 1 to 2 drops into the eye(s) up to every 3 to 4 hours

Comments:

  • This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients during the first 3 months of life.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For topical ophthalmic use only; not for injection.
  • Do not allow any solution to get into child's mouth.
  • Patients with heavily pigmented irides may require larger doses.
  • Wash hands and hands of child after use.
  • Compress the lacrimal sac for 2 to 3 minutes after instillation.

Patient advice:
  • Avoid touching tip of dropper to any surface as this may cause contamination.
  • Transient burning sensation may occur upon instillation.
  • Avoid driving or engaging in hazardous activities while pupils are dilated.
  • Protect eyes from bright illumination as sensitivity to light can occur.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by